-David C S Huang Researcher Activity Profile

Research Author Detailed Information 

David C S Huang Publication Rate By Year

David C S Huang has published 1 paper(s) in 1998, 2 paper(s) in 2006, 8 paper(s) in 2007, 6 paper(s) in 2008, for a total of 17 research publications in total.

David C S Dc Huang Author Information

LAST NAME: huang

FIRST NAME: David C S

INITIALS: dc

AFFILIATION:

Papers

David C S Huang's Publication Record

1. Structural insights into the degradation of Mcl-1 induced by BH3 domains. Year Published: 2007
The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria 3050, Australia.
2. The BH3-only protein bid is dispensable for DNA damage- and replicative stress-induced apoptosis or cell-cycle arrest. Year Published: 2007
The Walter and Eliza Hall Institute of Medical Research, Parkville 3050, Australia.
3. How the Bcl-2 family of proteins interact to regulate apoptosis. Year Published: 2006
The Walter and Eliza Hall Institute of Medical Research, and Department of Medical Biology, University of Melbourne, Parkville, Victoria 3010, Australia.
4. [Arginine metabolism in wine malolactic bacteria] Year Published: 2006
College of Enology, Northwest University of Agriculture & Forestry, Yangling 712100, China. putj@263.net
5. (alpha/beta+alpha)-peptide antagonists of BH3 domain/Bcl-x(L) recognition: toward general strategies for foldamer-based inhibition of protein-protein interactions. Year Published: 2007
Department of Chemistry, University of Wisconsin, Madison, Wisconsin 53706, USA.
6. A structural viral mimic of prosurvival Bcl-2: a pivotal role for sequestering proapoptotic Bax and Bak. Year Published: 2007
The Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, Victoria 3050, Australia.
7. PI-3K/Akt signal pathway plays a crucial role in arsenite-induced cell proliferation of human keratinocytes through induction of cyclin D1. Year Published: 2007
Nelson Institute of Environmental Medicine, New York University School of Medicine, Tuxedo, NY 10987, USA.
8. Gefitinib-induced killing of NSCLC cell lines expressing mutant EGFR requires BIM and can be enhanced by BH3 mimetics. Year Published: 2007
The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia.
9. Gefitinib-induced killing of NSCLC cell lines expressing mutant EGFR requires BIM and can be enhanced by BH3 mimetics. Year Published: 2007
The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia.
10. Gefitinib-induced killing of NSCLC cell lines expressing mutant EGFR requires BIM and can be enhanced by BH3 mimetics. Year Published: 2007
The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia.
11. Controlling the cell death mediators Bax and Bak: puzzles and conundrums. Year Published: 2008
The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia. fletcher@wehi.edu.au
12. Controlling the cell death mediators Bax and Bak: puzzles and conundrums. Year Published: 2008
The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia. fletcher@wehi.edu.au
13. A novel BH3 ligand that selectively targets Mcl-1 reveals that apoptosis can proceed without Mcl-1 degradation. Year Published: 2008
The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria 3050, Australia.
14. A novel BH3 ligand that selectively targets Mcl-1 reveals that apoptosis can proceed without Mcl-1 degradation. Year Published: 2008
The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria 3050, Australia.
15. Serum HDL level at acute stage of Kawasaki disease. Year Published: 1998
Department of Pediatrics, Veterans General Hospital, Koahsiung, Tajwan, R.O.C.
16. Phosphorylation of the Human Retinoid X Receptor {alpha} at Serine 260 Impairs Coactivator(s) Recruitment and Induces Hormone Resistance to Multiple Ligands. Year Published: 2008
McGill University Health Centre, Montreal, Quebec H3A 1A1, Canada.
17. Controlling the cell death mediators Bax and Bak: puzzles and conundrums. Year Published: 2008
The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia. fletcher@wehi.edu.au